Institutional Ownership
Kalaris Therapeutics Inc
CUSIP 482929106COMKLRSQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).